250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors

A list of 50 angel investors and VC funds that invest in Medical startups. We rank investors based on the number of investments they made in Medical companies. This investor list updates every month.

Top 50 Medical Startup Investors

Investor Medical investments
Innova Memphis 58
OrbiMed 44
New Enterprise Associates 42
ARCH Venture Partners 37
Bpifrance 36
Polaris Partners 35
F-Prime Capital 34
Connecticut Innovations 32
Versant Ventures 32
Qiming Venture Partners 31
Canaan Partners 29
Sequoia Capital China 28
Sofinnova Partners 28
Enterprise Ireland 28
Third Rock Ventures 28
Wisconsin Investment Partners 27
Wavemaker 360 27
Khosla Ventures 27
Atlas Venture 26
BioAdvance 25
BioVenture 24
Green Park & Golf Ventures 23
Alumni Ventures 23
Rock Health Capital 23
Lux Capital 23
Novo Holdings 23
Gaingels 22
Right Side Capital Management 22
MB Venture Partners 22
StartUp Health 21
General Catalyst 21
Parkwalk Advisors 21
Legend Capital 21
Houston Angel Network 20
High-Tech Grunderfonds 20
Alexandria Venture Investments 20
Deepbridge Capital 20
Boehringer Ingelheim Venture Fund 20
Google Ventures 20
UK Innovation & Science Seed Fund 20
HealthCap 19
Sanofi Ventures 19
Portfolia 19
TEDCO 19
Novartis Venture Fund 18
MPM Capital 18
KdT Ventures 18
Venrock 18
Domain Associates 18
EQT life science 18
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Innova Memphis VC Fund · Memphis, Tennessee, United States
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • United States, Argentina, United Kingdom
Portfolio highlights
  • Isomark Health — Isomark Health is a patented AI-based, real-time and 100% green breath technology that detects and prevents bacterial and viral infections.
  • Rantizo — Fly more acres, deliver better service. The equipment, tools, and expertise you need to be the grower's first call for drone spray services.
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
OrbiMed VC Fund · New York, New York, United States · 30 investments in the past 12 months
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Israel
Portfolio highlights
  • Tyra Biosciences — Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra is using its proprietary SNÅP platform, which is optimized to enable rapid and precise refinement of structural design through iterative molecular SNÅPshots, in orderto generate next-generation product candidates that are specifically designed to address acquired drug resistance and provide alternative treatment options. Tyra is initially focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR, family, which are altered in approximately 7% of all cancers. Tyra’s lead product candidate, TYRA-300, is designed to selectively inhibit FGFR3, with an initial focus on patients with bladder cancer.
  • Forward Therapeutics — Forward Therapeutics idelivers blockbuster oral agents for chronic inflammatory conditions. Science that impacts patient care.
  • Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases
New Enterprise Associates VC Fund · Menlo Park, California, United States · 41 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
  • Metronome — Metronome helps software companies launch, iterate, and scale their usage-based business models, with billing infrastructure that works at any size and stage.
  • Second Front Systems — The continuous accreditation and deployment of commercial software is crucial for U.S. national security missions. With Second Front Systems' Game Warden platform, you'll be achieving exactly that.
ARCH Venture Partners VC Fund · Chicago, Illinois, United States · 16 investments in the past 12 months
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, China, United Kingdom
Portfolio highlights
  • Accompany Health — Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions. Accompany Health offers primary care services such as chronic illness management and treatment of new symptoms. They also assist in the organization and coordination of care. There will be no more waiting rooms or lines for another form.Accompany Health cultivates long-term connections with the people they serve so that they know, without a doubt, that the team is there for them at all hours of the day and night, year after year.
  • Basking Biosciences — Basking Biosciences is a startup that’s developing a therapy to restore blood flow to the brain during ischemic stroke, preventing hemorrhage and long-term damage.
  • Moonwalk Biosciences — Pioneering precision epigenetic medicines We are hiring passionate, talented moonwalkers. See our open roles. Walk with Us Our science By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed. First in the field Moonwalk is the
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 89 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Switzerland
Portfolio highlights
  • Temo — Looking for an electric motor for your tender, or a practical outboard for your sailboat? Discover TEMO's range of electric motors for boats
  • Live Me Up — Live Shopping and Shoppable Video Shopify App for your e-commerce. Boost your conversion rate with Video Commerce and LiveMeUp.
  • Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.
Polaris Partners VC Fund · Boston, Massachusetts, United States · 20 investments in the past 12 months
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Singapore, Ireland
Portfolio highlights
  • UpDoc — UpDoc is a technology-enabled services firm that offers the world's first unique conversational AI platform for autonomous prescription management.
  • Cohere Health — Cohere Health can help your organization improve its utilization management process. We are transforming the way patients, physicians and health plans work together.
  • Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
F-Prime Capital VC Fund · Cambridge, Massachusetts, United States · 34 investments in the past 12 months
F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, United Kingdom, China
Portfolio highlights
  • Dispatch — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
  • Burro — Burro autonomous robots work side-by-side with farm workers to make agriculture more productive and sustainable.
  • Comanche Biopharma — Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia. The company aims to lower the risks of pregnancy and prematurity by safely sustaining natural pregnancy and allowing fetal maturation.
Connecticut Innovations VC Fund · Rocky Hill, Connecticut, United States · 12 investments in the past 12 months
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Funding Round
  • United States, Israel, Canada
Portfolio highlights
  • Cambium Carbon — Saving wood to save the planet. By revolutionizing supply chains, we introduce the world's first carbon smart material.
  • Vytyl Health Management — Vytyl Health Management delivers quality mental health care to adolescents and transitional-age youth. The organization firmly believes that connection forms the basis for healing. They recognize the significant challenges ahead but remain steadfast in their conviction that through collaborative efforts, barriers can be overcome, meaningful bondscan be formed, and vital assistance can be extended to those in greatest need.
  • Nest Collaborative — Nest Collaborative offers online lactation consults. Virtual appointments are available same-day & are covered in full by most insurance plans.
Versant Ventures VC Fund · Menlo Park, California, United States · 4 investments in the past 12 months
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 47 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Swap — Swap is city-based infrastructure of battery swapping stations for e-motorcycle riders. No more cords, no more hassle, battery is being swapped with a fully-charged battery within 9 seconds.
  • Ruining Bio — Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
  • Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
Canaan Partners VC Fund · Menlo Park, California, United States · 14 investments in the past 12 months
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, Israel, India
Portfolio highlights
  • Acesion Pharma — Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
  • Diligent Robotics — We build robots like Moxi that assist hospital staff with routine activities so they can focus on caring for patients.
  • AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Sequoia Capital China VC Fund · Beijing, Beijing, China · 48 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Artificial Intelligence
  • Series A, Series B, Series C
  • China, United States, Australia
Portfolio highlights
  • Shumeiwuwu — Shumeiwuwu is a cross-border e-commerce company that provides quality goods and services to consumers through global shopping.
  • Yacheng Network — Yacheng Network is a provider of information technology and software services that specializes in offering these services.
  • Lingdong Technology — Lingdong Technology is a provider of new energy thermal management systems, specializing in the development of thermal management systems for energy-efficient vehicles, as well as the production and manufacturing of controllers for thermal management systems and other related products.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 30 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • GlycoEra — GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.
  • Freya Biosciences — Freya Biosciences is a clinical-stage women’s health company pioneering a new class of microbial immunotherapies. It is based in Copenhagen and Boston.
  • DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 17 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Lative — Lative automates capacity planning, maximizing profitable sales growth & revenue efficiency for high-performance revenue teams.
  • Cytidel — Cytidel helps security teams reduce breaches, save time, and stay secure. Vulnerability Management and Cyber Risk Management, and Threat Intelligence Specialists
  • GREYSCOUT — Safeguard your reputation and increase revenue with GreyScout, the scalable, always-on platform for fighting IP infringement and grey market sellers.
Third Rock Ventures VC Fund · Boston, Massachusetts, United States · 4 investments in the past 12 months
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • Flare Therapeutics — Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, Flare’s team has uncovered ‘switch sites,’ druggable regions that are key targets fortranscription factor regulation to address mutations that cause disease. Our drug discovery to target switch sites has rapidly advanced, resulting in an emerging pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology with future potential in neurology, rare genetic disorders, immunology, and inflammation.
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • CARGO Therapeutics — CARGO Therapeutics develops CAR T-cell therapy to overcome cancer treatment resistance and address access barriers so that more patients can benefit from potentially curative therapies. The company is on a mission to outwit cancer by developing best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite commercially available autologousCARs advancements, these treatments are curative for less than half of all cancer patients. Furthermore, far too many patients are unable to access these potentially curative therapies due to other obstacles such as manufacturing, supply constraints, long turnaround times, and reimbursement barriers. CARGO's team is intensely focused on pursuing novel solutions to improve cancer treatment outcomes and experiences.
Wisconsin Investment Partners VC Fund · Madison, Wisconsin, United States · 3 investments in the past 12 months
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
  • BeeReaders — ## Build Setup
  • Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Wavemaker 360 VC Fund · Pasadena, California, United States · 6 investments in the past 12 months
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Canada
Portfolio highlights
  • 32Co — 32Co is a medical technology platform that helps general dentists deliver clear aligner orthodontics to their patients.
  • Pear Bio — Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
  • Nest Collaborative — Nest Collaborative offers online lactation consults. Virtual appointments are available same-day & are covered in full by most insurance plans.
Khosla Ventures VC Fund · Menlo Park, California, United States · 64 investments in the past 12 months
Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Headquartered in Menlo Park, Calif., Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech,digital health, medtech and diagnostics, therapeutics and frontier technology.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, India, United Kingdom
Portfolio highlights
  • Recraft — The first generative AI design tool that lets users create and edit digital illustrations, vector art, icons, and 3D graphics in a uniform brand style.
  • Overmoon — Overmoon offers a growing collection of family-oriented rentals.
  • Moonwalk Biosciences — Pioneering precision epigenetic medicines We are hiring passionate, talented moonwalkers. See our open roles. Walk with Us Our science By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed. First in the field Moonwalk is the
Atlas Venture VC Fund · Cambridge, Massachusetts, United States · 10 investments in the past 12 months
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • Triveni Bio — Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.
  • Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
  • Accent Therapeutics — Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth anddifferentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
BioAdvance VC Fund · Philadelphia, Pennsylvania, United States
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United States, Canada
Portfolio highlights
  • Senzo — SENZO HEALTH HAS DEVELOPED A REVOLUTIONARY LATERAL FLOW TEST WHICH DELIVERS THE SAME ACCURACY AS LABORATORY-BASED PCR, WITH RESULTS AVAILABLE WITHIN 10 MINUTES, AT A FRACTION OF THE COST.
  • KayoThera — KayoThera is a biotechnology company developing therapeutics used to cure late-stage and metastatic cancers. Its programs work on inhibiting a key enzyme that is responsible for protecting the cancer cells and depleting regulatory T-cells that intends to cure hitherto incurable cancers and give hope to patients. The company's mission is todevelop the first-in-class immuno- and targeted therapies to drive cures in advanced cancersKayoThera was founded in 2019 and is headquartered in Princeton, New Jersey.
  • Palvella Therapeutics — Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
BioVenture VC Fund · Suzhou, Jiangsu, China · 9 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
  • Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
  • Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Green Park & Golf Ventures VC Fund · Dallas, Texas, United States
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden
Portfolio highlights
  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Alumni Ventures VC Fund · Manchester, New Hampshire, United States · 86 investments in the past 12 months
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • StatusPro — StatusPro is a sports technology company that combines data with augmented and virtual reality to provide a suite of training and gaming products.
  • Roofer.com — Roofing on-demand using drones and AI, serving the Dallas, Fort Worth, and Austin Texas regions.
  • Bluewhite — Blue White Robotics offers custom-made, on-time, and affordable testing and experiment solutions based on military experiment methodologies. It was established by a group of former Israeli Air Force pilots and engineers. BWR works in close cooperation with a variety of universities, vehicle manufacturers, and startups in Israel and worldwide.
Rock Health Capital VC Fund · San Francisco, California, United States
We invest in remarkable entrepreneurs working at the intersection of healthcare and technology.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, Denmark
Portfolio highlights
  • WellTheory — Our programs support autoimmune lifestyle changes with an actionable and supportive membership experience, no matter where you are in your autoimmune journey.
  • Oula Health — Oula is a modern maternity clinic combining the best of obstetrics and midwifery care to deliver an evidence-based and personalized pregnancy experience
  • Rosarium Health — Rosarium Health is a platform that connects service providers (home contractors and occupational therapists) with customers to execute accessible house assessments and accessible home modifications at a client's primary home, leased property, or company.
Lux Capital VC Fund · New York, New York, United States · 24 investments in the past 12 months
Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high-growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Seed, Series B
  • United States, Canada, United Kingdom
Portfolio highlights
  • Sakana AI — We are creating a new kind of foundation model based on nature-inspired intelligence.
  • Coris — Coris helps Financial Services companies better manage small business risk by providing alternate credit quality data on merchants and constantly monitor businesses for changes in business quality
  • Atavistik Bio — Atavistik Bio is harnessing the power of protein-metabolite interactions to add a new lens to drug discovery.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 14 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • EnergyRe — EnergyRe is at the center of the clean energy future.
  • Revagenix — Game-changing approach to anti-infectives
  • Claris Biotherapeutics — Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
Gaingels VC Fund · New York, New York, United States · 81 investments in the past 12 months
Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.
Show more
Investment focus
  • Software, Health Care, FinTech
  • Seed, Series A, Series B
  • United States, Canada, Mexico
Portfolio highlights
  • Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
  • Alinea — Alinea offers a social investing platform for crypto, stocks and playlists. We offer fractional investing, $0 commission on investments, and a minimum as low as $1.
  • Shimmer — Weekly guided support circles to learn the skills you need to combat stress and anxiety. Evidence-based curriculum developed by doctors, therapists, and peers
Right Side Capital Management VC Fund · San Francisco, California, United States · 8 investments in the past 12 months
Right Side Capital Management is a venture capital firm that helps startups build their company. It invests exclusively in the pre-seed round of technology startups and makes 75-100 investment per year. The firms prefers to invest in diversified technology sectors such as the internet and cloud companies.RSCM was established in 2010 and is basedin San Francisco, California.
Show more
Investment focus
  • Software, SaaS, Health Care
  • Seed, Pre-Seed, Convertible Note
  • United States, Canada, United Kingdom
Portfolio highlights
  • ASETS — ASETS develops software for engineers and created the first cloud-based Integrated Design Suite.
  • Camlann — We're Camlann GamesAn Indie Game Publisher That Performs We back passionate developers, vibrant worlds and the most unforgettable stories ever told in indie PC games Our Games Wishlist on Steam Wishlist on Steam Featured on PCGamer We're New. So Why Should You Work With Us? Learn more 0 + Years Independent Game Publishing Experience 0
  • Precision Compounding — Precision Compounding compounds customized medications to meet the specific needs of patients and their pets. They benefit patients by providing formulations customized for dosage, taste, and ingredients. Their services include proscripts, concierge pick-up options, and professional delivery. They respond to customer inquiries by phone, contactform, and email.
MB Venture Partners VC Fund · Memphis, Tennessee, United States
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series B, Series C
  • United States, Israel
Portfolio highlights
  • Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
  • SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
  • Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
StartUp Health VC Fund · New York, New York, United States · 4 investments in the past 12 months
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
  • Health Care, Wellness, Medical
  • Seed, Funding Round, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Pear Suite — Pear Suite enables anyone—community health workers, other healthcare staff, and volunteers—to assess and address the social drivers of health for older adults in a scalable, cost-effective, and person-centered way.
  • Hidoc Consult — Hidoc Consult has a global pool of specialist who serves you with specialist consultation within 15 minutes at a much lesser cost. It has EMR integrated to maintain all data of the cases consulted.This is a global virtual platform to end all your concerns related to Specialist Consultation. Hidoc Consult has tried to solve the major gaps in healthcare services
General Catalyst VC Fund · Cambridge, Massachusetts, United States · 76 investments in the past 12 months
Investing in powerful, positive change that endures
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • Chalk — Chalk is a data platform that powers machine learning and generative AI. Chalk's best-in-class developer experience enables data teams to declare features and their dependencies with idiomatic Python in online, streaming, and batch environments. Chalk compiles these definitions into parallel pipelines that run on a Rust-based engine. Thesepipelines use the same source code to serve temporally consistent training sets to data scientists and live feature values to models. This re-use ensures that feature values from online and offline contexts match and dramatically cuts development time. With Chalk, engineers, data scientists, and analysts can focus on their unique products while Chalk seamlessly handles data infrastructure.
  • Harbor Health — Harbor Health is a multi-specialty clinic group that provides smarter health care using technology. The company co-creates a health path that is dedicated to knowing individuals' health goals with the guidance of specialists when needed. Harbor Health was founded in 2022 and is based in Austin, Texas.
  • Civic Roundtable — The collaboration platform for public service that is powering a more integrated, collaborative, effective government.
Parkwalk Advisors VC Fund · London, England, United Kingdom · 15 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Fresh Check — Fresh Check is a simple sticker that you put inside the packaging of food that changes colour when your food has actually gone off, not when the use-by date says so.
  • Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
Legend Capital VC Fund · Beijing, Beijing, China · 36 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
  • Dearer Medical — Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses.
  • Sunshine Hydrogen — Sunshine Hydrogen designs and manufactures its own PWM hydrogen production power supply.
Houston Angel Network VC Fund · Houston, Texas, United States
The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • CaseCTRL — Schedule surgeries with ease using AI-powered surgical scheduling. Fewer canceled cases, conflicts, and misorders. More surgery and time for patients!
  • Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
  • Amplified Sciences — Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and providesa very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data.
High-Tech Grunderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 50 investments in the past 12 months
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
  • SKY ENGINE AI — About Sky EngineSky Engine is an advanced data science technology and research company that develops innovative software solutions to improve computer vision. The company markets the Sky Engine deep learning platform, which is the next-generation of self-learning AI system for image and video analysis applications. The company was founded as aresearch and scientific spin-off in UK.About Sky Engine PlatformThe Sky Engine evolutionary AI platform for the deep learning in virtual reality is designed to overcome the complex object recognition challenges of modern machine/computer vision. It represents the future of self-learning in artificial intelligence technology, supporting efficient and cost effective workflows. Many image recognition tasks require acquisition of large amounts of data and manual data labelling. Sky Engine is designed to replace that. Sky Engine efficiently drives self-learning processes and offers advanced features for object discrimination, workflow automation and adaptive deep learning. Sky Engine is designed for tomorrow’s requirements in advanced analytics and decision support enabling AI business transformation.About Sky Engine client solutionsSky Engine creates flexible and innovative AI vision solutions tailored to customer needs and supports a wide range of industries, providing systems for a variety of data science needs, ensuring business partners get greater value from existing equipment.
  • BOX ID Systems — BOX ID Systems develops and offers an end-to-end location & process mining solution to cost effectively track millions of logistics assets digitally throughout the industrial supply chain across Europe and the World - including site-to-site, on-premises and indoor buildings digital twin of supply chain processes. The system is built on aspecialized analytics software platform, sensorik tracking devices and efficient data-, device- and user-management tools, including functions to support process automation and optimization. Industrial and automotive production customers benefit from making their logistics processes more efficient and cost optimized, with 100% transparency within their critical processes throughout the entire supply chain.
Alexandria Venture Investments VC Fund · Pasadena, California, United States · 21 investments in the past 12 months
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, France, Canada
Portfolio highlights
  • Tome Biosciences — Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
  • Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
  • Remix Therapeutics — Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
Deepbridge Capital VC Fund · Chester, Cheshire, United Kingdom · 2 investments in the past 12 months
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Australia, Singapore
Portfolio highlights
  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 4 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Google Ventures VC Fund · Mountain View, California, United States · 48 investments in the past 12 months
GV supports innovative founders moving the world forward.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • StatusPro — StatusPro is a sports technology company that combines data with augmented and virtual reality to provide a suite of training and gaming products.
  • FlutterFlow — FlutterFlow is an online app builder that lets users easily build native apps. Build fully functional apps with Firebase integration, API support, animations, and more. Export your code or even easier deploy directly to the app stores!
  • Granata Bio — Granata Bio is a biopharma company focused on women's health and infertility. Our mission and focus is to create access for fertility patients by introducing new therapeutic solutions.
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 16 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Oxford Space Systems — Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS'structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. .
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Sanofi Ventures VC Fund · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Israel, Denmark
Portfolio highlights
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
  • ROME Therapeutics — ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier inbiology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.
  • ReCode Therapeutics — ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
Portfolia VC Fund · San Mateo, California, United States · 12 investments in the past 12 months
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Series B
  • United States, Canada, Argentina
Portfolio highlights
  • Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
  • Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
  • Harvest Thermal — We are manufacturers of the cleanest home energy solution on the market today. We offer a cloud-enabled, ultra-clean heating, cooling and hot water system for residential customers. The brains of the system is our award-winning Harvest Pod that slashes carbon emissions, saves on utility bills, and
TEDCO VC Fund · Columbia, Maryland, United States · 21 investments in the past 12 months
TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Grant
  • United States
Portfolio highlights
  • ReBokeh — Simply Seeing Designed to Enhance Vision, Not Overpower it.The ReBokeh app was designed with moderate vision impairment in mind.Create custom video filters, unique to you and your environment - simply see the world how you want to. Get it Now! AS SEEN ON Our vision at ReBokeh is to make it simple for all individuals to
  • PediaMetrix — Founded by alumni entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford, PediaMetrix’s mission is to bring AI and computer vision to pediatrics to lower the healthcare costs and improve outcomes. PediaMetrix’s lead product, SoftSpot, enables early detection and management of the most common conditions with head shape abnormalities innewborns. PediaMetrix is a Delaware company founded in 2018.
  • Escalate USA — At Escalate, we solve the talent crisis for retail corporations. We increase employee retention and the internal pool of skilled middle-wage candidates by providing frontline workers with weekly asynchronous online training that leads to industry-recognized certifications and upward mobility.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 4 investments in the past 12 months
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
MPM Capital VC Fund · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
Powering Breakthroughs in Life Sciences
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • AstronauTx — AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
  • Deka Biosciences — Deka BioSciences, Inc. is committed to developing and delivering life-changing medicines to patients with cancer and inflammatory diseases.
  • ReCode Therapeutics — ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.
KdT Ventures VC Fund · Austin, Texas, United States · 3 investments in the past 12 months
KdT Ventures is the standard for early-stage frontier science investing.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United States, Israel, Germany
Portfolio highlights
  • Andes — Andes empowers microbes to enable positive action against climate change.
  • Aperiam Bio — Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States.
  • SURGE Therapeutics — SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
Venrock VC Fund · Palo Alto, California, United States · 14 investments in the past 12 months
Building Companies that Shape the Future
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series B, Series A, Series C
  • United States, Canada, China
Portfolio highlights
  • SmithRx — Discover SmithRx's innovative approach to pharmacy benefits. We're transforming healthcare with modern, transparent technology, connecting payers, pharmacies, and patients for more efficient and cost-effective drug delivery.
  • Zero Networks — We make microsegmentation the easiest & most effective way to protect your company. Enable MFA network solution anywhere to block ransomware & advanced attacks.
  • Accompany Health — Accompany Health provides comprehensive in-home care to patients who live in sometimes underserved regions. Accompany Health offers primary care services such as chronic illness management and treatment of new symptoms. They also assist in the organization and coordination of care. There will be no more waiting rooms or lines for another form.Accompany Health cultivates long-term connections with the people they serve so that they know, without a doubt, that the team is there for them at all hours of the day and night, year after year.
Domain Associates VC Fund · San Diego, California, United States
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices,while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, Canada, Estonia
Portfolio highlights
  • Epic Sciences — Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
  • Antios Therapeutics — This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I'm a bike messenger
  • Fractyl Health — Our vision is to develop transformative therapies that have the potential to prevent and eliminate metabolic diseases. We are a mission-driven team of innovators, singularly
EQT life science VC Fund · Amsterdam, Noord-Holland, The Netherlands · 6 investments in the past 12 months
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Investors by industry
Investors by country
Investors in Medical by country
Angel investors in Medical by country
VC Funds in Medical by country